Download Summary

Survey
yes no Was this document useful for you?
   Thank you for your participation!

* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project

Document related concepts

Vaccine wikipedia , lookup

Childhood immunizations in the United States wikipedia , lookup

DNA vaccination wikipedia , lookup

Neglected tropical diseases wikipedia , lookup

Transmission (medicine) wikipedia , lookup

Vaccination wikipedia , lookup

Infection control wikipedia , lookup

Sarcocystis wikipedia , lookup

Hygiene hypothesis wikipedia , lookup

Sociality and disease transmission wikipedia , lookup

Germ theory of disease wikipedia , lookup

Infection wikipedia , lookup

Globalization and disease wikipedia , lookup

Tuberculosis wikipedia , lookup

Transcript
Summary
Since many millennia, mycobacteria cause infectious diseases in humans. The most life-threatening of
these diseases is tuberculosis (TB), which is caused by Mycobacterium tuberculosis. As the current BCG
vaccine does not fully protect against TB and antibiotic resistant strains appear due to the inappropriate
use of medicines, it is essential to study the virulence mechanisms of M. tuberculosis in order to prevent
TB from becoming an untreatable disease. These mechanisms were studied in this thesis, by using the
genetically closely to M. tuberculosis related species Mycobacterium marinum as a model for pathogenic
mycobacteria. The specialized protein transport system ESX-5, which is unique for pathogenic species, was
studied in detail and found to play an important role in the infection process and the uptake of fatty acids,
which is linked to the initiation of latency. For the homologous and highly important ESX-1 protein
transport system, a new substrate and regulator protein could be identified. Finally, a genome-wide DNA
sequencing study has led to the identification of mycobacterial factors that are required for a successful
infection of phagocytes derived from several types of hosts. Together, these studies can contribute to the
development of new vaccines, for example by targeting candidate virulence factors found in the
sequencing study, or aid in the development of new therapeutic strategies aimed to increase effectiveness
of TB treatment.